The novel IL-17A and IL-17F inhibitor has been approved for moderate to severe hidradenitis suppurativa, a chronic and ...
This approval is the fifth overall for bimekizumab (Bimzelyx; UCB Pharma) in the US, and they all have come in the last 13 ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Kamada Ltd. Third Quarter 2024 ...
The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial urinary tract infections (UTI) in adult women, the health regulator said on ...
Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...
Zacks.com on MSN9d
RNA Stock Hits Record High on Entering the Cardiac Disease SpaceShares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its ...
Compounded drugs are made by pharmacies or manufacturers other than the companies that make FDA-approved versions of the medicines, and they typically are allowed when drugs are in shortage. The drug ...
Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...
Revuforj is the first and only menin inhibitor approved by the FDA. It works by preventing rearrangements in ... and bacterial infection (17%). The most common adverse reactions were hemorrhage (53%), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback